High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resec...
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024
Project: PhaseControl
Updated at: 27-04-2024